Physician profile
Prasanth Nuthakki
NPI 1114046455
$6,818.98
in general payments reported to CMS, 2019-2025
28 companies · $553 in 2025
The $553 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $1,238 · 2021: $733 · 2022: $917 · 2023: $1,205 · 2024: $532 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,289.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,718.64 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Accurian |
| Abbott Laboratories | $1,105.42 | 2019-2023 | Proclaim |
| Medtronic USA, INC. | $1,078.67 | 2019-2020 | |
| Boston Scientific Corporation | $459.38 | 2019-2021 | |
| Painteq LLC | $295.61 | 2023-2024 | Painteq |
| Pacira Pharmaceuticals Incorporated | $212.00 | 2019 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Horizon Therapeutics Plc | $120.28 | 2021-2022 | |
| Nevro Corp. | $80.08 | 2019-2023 | Senza |
| Pacira Therapeutics, INC. | $79.18 | 2019 | |
| Ibsa Pharma INC. | $78.65 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $53.42 | 2019 | |
| Spr Therapeutics, INC | $43.85 | 2020 | |
| Vertos Medical, INC. | $42.81 | 2021-2024 | Mild Device Kit |
| Intercept Pharmaceuticals, INC. | $37.26 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $31.73 | 2021 | |
| Mml US, INC. | $30.18 | 2023 | Reactiv8 |
| Alexion Pharmaceuticals, INC. | $29.79 | 2020 | |
| Foundation Fusion Solutions, LLC | $17.15 | 2025 | |
| Collegium Pharmaceutical, INC. | $15.95 | 2025 | Belbuca |
| Vertiflex, INC. | $15.61 | 2019 | |
| Nalu Medical, INC. | $15.43 | 2024 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $14.27 | 2020 | |
| Radius Health, INC. | $13.58 | 2022 | |
| Assertio Therapeutics, INC. | $13.24 | 2019 | |
| Si-Bone, INC. | $12.53 | 2021 | |
| Pfizer INC. | $12.53 | 2019 | |
| Hydrocision, INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasanth Nuthakki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.